Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference22 articles.
1. Ministry of Food and Drug Safety (MFDS). Press release: authorization for the Novavax COVID-19 vaccine (NVX-CoV2373) [Internet]. Cheongju: MFDS; 2022 [cited 2023 Mar 1]. Available from: https://www.mfds.go.kr/brd/m_99/view.do?seq=46068&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=Korean.
2. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant;Shinde;N Engl Med,2021
3. Formica N, Mallory R, Albert G, et al. Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial. PLos Med 18(10): e1003769.
4. Safety and Efficacy of NVX-CoV2373 in Covid-19 Vaccine;Heath;N Engl J Med,2021
5. Efficacy and Safety of NVX-Cov2373 in Adults in the United States and Mexico;Dunkle;N Engl J Med,2022
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献